Contract Number HDTRA1-09-C-0046 between Defense Threat Reduction Agency and AVI BioPharma, IncAttachment Description • August 10th, 2009 • Avi Biopharma Inc • Pharmaceutical preparations
This letter constitutes a contract on the terms set forth herein and signifies the intention of the Defense Threat Reduction Agency to execute a formal Cost-Plus-Fixed-Fee Contract with AVI BioPharma, Inc. Services shall be provided as set forth in Attachment 1, 2 and 3, which are incorporated into and made a part of this Letter Contract, upon the terms and conditions therein stated.
FIRST AMENDMENT TO SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 10th, 2009 • Avi Biopharma Inc • Pharmaceutical preparations
This FIRST AMENDMENT TO SPONSORED RESEARCH AGREEMENT (the “Amendment”) is entered into effective as of May 28, 2009 (“Amendment Date”), by and between AVI BioPharma, Inc., an Oregon corporation having offices at 4575 SW Research Way, Suite 200, Corvallis, OR 97333 (the “Company”), and Charley’s Fund, Inc., a 501(c)(3) tax-exempt public non-profit organization with a mailing address of P.O. Box 297, South Egremont, MA 01258 (the “Sponsor”) (each a “Party” and together the “Parties”), and amends that certain SPONSORED RESEARCH AGREEMENT, effective as of October 12, 2007, by and between the Parties (the “Agreement”), as follows.
EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2009 • Avi Biopharma Inc • Pharmaceutical preparations • Washington
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made on this 15th day of May, 2009, by and between AVI BioPharma, Inc., an Oregon corporation, with its principal office at 4575 SW Research Way, Suite 200, Corvallis, Oregon, (“Company”), and Paul Medeiros, 700 Mixsell Street, Easton, Pennsylvania 18042 (“Employee”).
